Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 340

1.

Antiviral activity of four types of bioflavonoid against dengue virus type-2.

Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S.

Virol J. 2011 Dec 28;8:560. doi: 10.1186/1743-422X-8-560.

2.

Novel antiviral activity of baicalein against dengue virus.

Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S.

BMC Complement Altern Med. 2012 Nov 9;12:214. doi: 10.1186/1472-6882-12-214.

3.

Extract of Scutellaria baicalensis inhibits dengue virus replication.

Zandi K, Lim TH, Rahim NA, Shu MH, Teoh BT, Sam SS, Danlami MB, Tan KK, Abubakar S.

BMC Complement Altern Med. 2013 Apr 29;13:91. doi: 10.1186/1472-6882-13-91.

4.

Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus.

Johari J, Kianmehr A, Mustafa MR, Abubakar S, Zandi K.

Int J Mol Sci. 2012 Dec 7;13(12):16785-95. doi: 10.3390/ijms131216785.

5.

Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.

Lee JC, Tseng CK, Wu YH, Kaushik-Basu N, Lin CK, Chen WC, Wu HN.

Antiviral Res. 2015 Apr;116:1-9. doi: 10.1016/j.antiviral.2015.01.002. Epub 2015 Jan 19.

PMID:
25614455
6.

Narasin, a novel antiviral compound that blocks dengue virus protein expression.

Low JS, Wu KX, Chen KC, Ng MM, Chu JJ.

Antivir Ther. 2011;16(8):1203-18. doi: 10.3851/IMP1884.

PMID:
22155902
7.

Baicalin, a metabolite of baicalein with antiviral activity against dengue virus.

Moghaddam E, Teoh BT, Sam SS, Lani R, Hassandarvish P, Chik Z, Yueh A, Abubakar S, Zandi K.

Sci Rep. 2014 Jun 26;4:5452. doi: 10.1038/srep05452.

8.

Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes.

Hassandarvish P, Oo A, Jokar A, Zukiwski A, Proniuk S, Abu Bakar S, Zandi K.

J Antimicrob Chemother. 2017 Sep 1;72(9):2438-2442. doi: 10.1093/jac/dkx191.

PMID:
28666323
9.

Flavone enhances dengue virus type-2 (NGC strain) infectivity and replication in vero cells.

Zandi K, Lani R, Wong PF, Teoh BT, Sam SS, Johari J, Mustafa MR, AbuBakar S.

Molecules. 2012 Feb 28;17(3):2437-45. doi: 10.3390/molecules17032437.

10.

Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.

Chew MF, Tham HW, Rajik M, Sharifah SH.

J Appl Microbiol. 2015 Oct;119(4):1170-80. doi: 10.1111/jam.12921. Epub 2015 Sep 8.

PMID:
26248692
11.

Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6/36 cells.

Farias KJ, Machado PR, da Fonseca BA.

ScientificWorldJournal. 2013;2013:282734. doi: 10.1155/2013/282734. Epub 2013 Jan 31.

12.

Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.

Wang QY, Bushell S, Qing M, Xu HY, Bonavia A, Nunes S, Zhou J, Poh MK, Florez de Sessions P, Niyomrattanakit P, Dong H, Hoffmaster K, Goh A, Nilar S, Schul W, Jones S, Kramer L, Compton T, Shi PY.

J Virol. 2011 Jul;85(13):6548-56. doi: 10.1128/JVI.02510-10. Epub 2011 Apr 20.

13.

Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.

Pelliccia S, Wu YH, Coluccia A, La Regina G, Tseng CK, Famiglini V, Masci D, Hiscott J, Lee JC, Silvestri R.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):1091-1101. doi: 10.1080/14756366.2017.1355791.

PMID:
28776445
14.

Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.

Soto-Acosta R, Bautista-Carbajal P, Syed GH, Siddiqui A, Del Angel RM.

Antiviral Res. 2014 Sep;109:132-40. doi: 10.1016/j.antiviral.2014.07.002. Epub 2014 Jul 11.

PMID:
25017471
15.

Inhibition of dengue virus by an ester prodrug of an adenosine analog.

Chen YL, Yin Z, Lakshminarayana SB, Qing M, Schul W, Duraiswamy J, Kondreddi RR, Goh A, Xu HY, Yip A, Liu B, Weaver M, Dartois V, Keller TH, Shi PY.

Antimicrob Agents Chemother. 2010 Aug;54(8):3255-61. doi: 10.1128/AAC.00397-10. Epub 2010 Jun 1.

16.

Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan.

Talarico LB, Noseda MD, Ducatti DR, Duarte ME, Damonte EB.

J Gen Virol. 2011 Jun;92(Pt 6):1332-42. doi: 10.1099/vir.0.028522-0. Epub 2011 Feb 16.

PMID:
21325483
17.

A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.

Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT.

Chem Biol Drug Des. 2015 Nov;86(5):1093-104. doi: 10.1111/cbdd.12576. Epub 2015 May 20.

PMID:
25891143
18.

The antimicrobial peptide HS-1 inhibits dengue virus infection.

Monteiro JMC, Oliveira MD, Dias RS, Nacif-Marçal L, Feio RN, Ferreira SO, Oliveira LL, Silva CC, Paula SO.

Virology. 2018 Jan 15;514:79-87. doi: 10.1016/j.virol.2017.11.009. Epub 2017 Nov 16.

PMID:
29153860
19.

Novel antiviral activity of bromocriptine against dengue virus replication.

Kato F, Ishida Y, Oishi S, Fujii N, Watanabe S, Vasudevan SG, Tajima S, Takasaki T, Suzuki Y, Ichiyama K, Yamamoto N, Yoshii K, Takashima I, Kobayashi T, Miura T, Igarashi T, Hishiki T.

Antiviral Res. 2016 Jul;131:141-7. doi: 10.1016/j.antiviral.2016.04.014. Epub 2016 May 12.

20.

Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.

Laosutthipong C, Kanthong N, Flegel TW.

Antiviral Res. 2013 Jun;98(3):449-56. doi: 10.1016/j.antiviral.2013.04.011. Epub 2013 Apr 17.

PMID:
23603496

Supplemental Content

Support Center